Health Condition 1: O- Medical and Surgical
Conditions
Interventions
Intervention1: Transurethral Lignocaine: Patient in Group L will receive transurethral bladder irrigation of normal saline with 0.02% lidocaine at the end of surgery with a contact time of 10 mins
Con
Sponsors
PGIMER, Chandigarh, India
Eligibility
Inclusion criteria
Inclusion criteria: 1.Age 18-65 years 2.ASA-PS I/II 3.Patients undergoing elective TURBT surgeries under general anesthesia
Exclusion criteria
Exclusion criteria: 1. Patient Refusal to give consent for the study 2.ASA PS more than 2 3.Patients who are known cases of arrhythmias, heart block, atrial fibrillation or any cardiac dysfunction 4.Severe respiratory diseases 5.Cirrhosis of the liver 6.History of urinary catheter in situ 7.Allergy to lidocaine 8.Allergy to solifenacin
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the incidence and severity of CRBD in patients receiving transurethral lidocaine irrigation compared to those receiving oral Solifenacin prophylaxis and to demonstrate non-inferiority.Timepoint: From start of the surgery to 24 hours after surgery | — |
Secondary
| Measure | Time frame |
|---|---|
| The assessment of following factors during post operative period 1.Patient satisfaction score (7-point Global Perceived Effects Scale) 2.NRS for pain score at 0,1,2,6 and 24 hours after surgery. 3.QoR-15 score at 24 hours 4.Rescue analgesia requirement Timepoint: From 0 to 24 hours post surgery | — |
Countries
India
Contacts
Public ContactAjay Singh
PGIMER CHANDIGARH
Outcome results
None listed